BENTSUR RON bought NVCT
January 6, 2026 · Form 4 insider transaction
BENTSUR RON bought 150,000 shares of Nuvectis Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderBENTSUR RON
Role—
CompanyNuvectis Pharma, Inc. (NVCT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 9, 2026
Shares owned after3,675,924
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates.; Includes shares of restricted common stock.